Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
New study identifies genetic changes in patients who progress to esophageal cancer
Findings in precancerous Barrett’s esophagus a step toward improved screening, prevention
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Finding metabolites relevant to esophageal adenocarcinoma
From the Vaughan Lab, Public Health Sciences Division
‘Finding their calling’: Cancer caregivers join larger cause after helping loved ones
Some family caregivers devote their lives to that larger work, shifting the health care landscape
Drs. Michael Emerman and Nina Salama elected to Fellowship in the American Academy of Microbiology
Celebrating faculty and staff achievements
Fred Hutch researcher receives grant for esophageal cancer screening study
Incidence of esophageal cancer has increased fivefold since the 1970s
What's your cancer color?
There’s a cascade of cancer-awareness colors, but how do they get decided and do they divide or unite?
Researchers identify four genetic variants that are linked to esophageal cancer and its precursor, Barrett’s esophagus - Fred Hutchinson Cancer Research Center
Findings from the first large-scale, genome-wide association study of esophageal adenocarcinoma may lead to new screening tools for those at high risk
Esophageal cancer risk reduced by lifestyle factors - Fred Hutchinson Cancer Research Center
April is Esophageal Cancer Awareness Month
Vaughan secures $7.9 million for esophageal cancer research
National Cancer Institute grant to evaluate genetic susceptibility for Barrett’s esophagus and esophageal adenocarcinoma
Hutchinson Center researcher secures $7.9 million NCI grant for esophageal cancer research
Study to evaluate genetic risk for Barrett’s esophagus and esophageal adenocarcinoma
Belly fat linked to Barrett's esophagus
PHS study links central body weight, precancerous condition
On target to halt esophageal cancer
Aspirin, other nonsteroidal anti-inflammatory drugs significantly reduce esophageal-cancer risk in people with most aggressive form of Barrett's
Aspirin significantly reduces esophageal-cancer risk in people with most-aggressive form of Barrett's esophagus
Study also identifies biomarkers that predict which patients are most likely to get cancer
Fighting cancer with NSAIDs
Regular use of aspirin and other nonsteroidal anti-inflammatory drugs may reduce esophageal-cancer risk for people with Barrett's esophagus